Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd (JSE: SOL; NYSE: SSL), announced a collaboration to manufacture and commercialize rhamnolipids and mannosylerythritol lipids (MELs). This collaboration expands the partnership between the two companies announced in March 2022 to develop and commercialize another biosurfactant product, sophorolipids.
www.sasol.com
